Law Firm Probes Option Care Health Amid Shareholder Concerns
Monteverde & Associates PC is investigating Option Care Health over potential shareholder claims, the New York firm announced.
A New York-based securities law firm has launched an investigation into Option Care Health, Inc., the home and alternate-site infusion therapy company traded on the Nasdaq under the ticker OPCH, according to an announcement released Monday.
Monteverde & Associates PC, led by class action attorney Juan Monteverde, said it is examining potential claims on behalf of Option Care Health shareholders. The firm said it has recovered millions of dollars for investors in prior cases and was recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report.
Read more Law Firm Investigates Pacira BioSciences Over Shareholder Rights →
The probe follows a pattern common in mergers-and-acquisitions litigation, where plaintiffs' attorneys scrutinize deal terms, board disclosures, and fiduciary duties owed to shareholders before or during significant corporate transactions. The announcement did not specify the precise nature of the alleged wrongdoing or the transaction under review.
Shareholders considering legal action typically have limited windows to seek lead-plaintiff status in class action proceedings, making early awareness of such investigations consequential for investors holding affected securities. No court has made any finding of wrongdoing against Option Care Health at this stage.
Continue reading at All Financial Services & Investing
